HOVON 146

HOVON 146

A phase II trial where blinatumomab is added to prophase and consolidation therapy in precursor B-acute lymphoblastic leukemia in adults.


Study Treatments

Blinatumomab IV added to prophase and consolidation therapy.


Inclusion criteria:


Exclusion criteria


Participating sites


Link